Recurrent/metastatic relapse after definitive treatment for HNSCC: timing, patterns, and survival
Patients with locoregionally advanced HNSCC treated with CRT and surgery plus CRT represent a high-risk cohort with rapid R/M disease and poor survival, who need improved therapeutic options.
Authors
- W-Y. P. Hwang (ORCID: https://orcid.org/0000-0003-1563-8683)
- Kewen Qu (ORCID: https://orcid.org/0000-0001-5532-4107)
- Margaret Stalker (ORCID: https://orcid.org/0000-0001-9493-7221)
- Roger Cohen
- Lova Sun
Institutions
- University of Pennsylvania (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-03-11
- DOI
- https://doi.org/10.3389/fonc.2026.1738860
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00